Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
First-in-human trial of Dz13 for nodular basal-cell carcinoma
R., Bigelow, D
-20C, 1 month (sealed storage, away from moisture and light, under nitrogen)
The total cost of diabetes in the US in 2022 was estimated to be $412.9 billion, including $306.6 billion attributed to direct medical costs and $106.3 billion attributed to indirect costs, underscoring the need for low-cost, effective medications to address the growing incidence and financial burden
US$ 20.77
US$ 21.09
US$ 24.03
US$ 20.23
